Houston (1)

Advanced Carcinoid Tumor (1)

Digestive System Neuroendocrine Neoplasm (1)

Multiple Endocrine Neoplasia Type 1 (1)

Neuroendocrine Neoplasm (1)

Unresectable Carcinoid Tumor (1)

Recruiting (1)

phase 2 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

everolimus (1)

lenvatinib (1)

drug (1)

Other (1)

Interventional (1)

digestive system neuroendocrine neoplasm

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Sep 22, 2022